The National Institutes of Health recently presented a budget for developing more effective treatment and prevention strategies for Alzheimer’s disease and other dementias by the year 2025, director Francis S. Collins, MD, PhD, announced in a statement.
The Professional Judgement Budget, also referred to as a Bypass Budget, proposes $323,355 in additional resources above the current baseline appropriations for fiscal year 2017.
“Through this plan, NIH is proposing an investment in hope — hope grounded in biomedical research,” he said. “We believe that if we expand and build upon our base of scientific knowledge, we can identify and implement the strategies for combating Alzheimer’s disease [AD] that are so desperately needed.”
The largest asks included more funding for translational research and clinical intervention ($92,800), molecular pathogenesis and physiology ($68,680), and epidemiology ($45,100).
Other areas for which increased funds were requested include diagnosis; assessment and disease monitoring ($36,500); AD-Related Dementias ($35,375); research resources ($31,050); care and caregiver support ($9,800); staffing, support, and miscellaneous ($4,050).
The budget includes specific, targeted milestones, outlines areas poised for future discoveries, and prioritizes areas of research that could benefit the most from investment by the year 2017.
The number of AD cases is expected to triple by 2050 to 13.8 million as the number of people aged 65 years and older age, unless new ways to prevent the disease are discovered. In 2010, AD cost the US healthcare system an estimated $159 billion to $215 billion. These costs are projected to increase to between $319 billion and $511 billion by 2040.
- National Institutes of Health. “Reaching for a Cure: Alzheimer’s Disease and Related Dementias Research at NIH 60 Bypass Budget Proposal for Fiscal Year 2017.” Available here: https://www.nia.nih.gov/budget-files/Reaching-for-a-Cure-Alzheimers-Disease-and-Related-Dementias-Research-at-NIH.pdf. Accessed 29 Jul 2015.
This article originally appeared on Psychiatry Advisor